Johnson Laura L. 4
4 · Kintara Therapeutics, Inc. · Filed Sep 22, 2021
Insider Transaction Report
Form 4
Douglass Laura L.
Director
Transactions
- Award
Options (Right to Buy)
2021-09-22+100,000→ 100,000 totalExercise: $1.24Exp: 2031-09-22→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021.